Recombinant Rituximab 抗体
MALS verified
适用: 人
ELISA, LF
宿主: 小鼠
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原 See all Rituximab products
- Rituximab
- 抗体类型
- Recombinant Antibody
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This Rituximab antibody is un-conjugated
-
应用范围
- ELISA, Lateral Flow (LF)
- 原理
- Anti-Rituximab Antibody (MALS verified)
- 产品特性
- Anti-idiotypic Antibodies
- 质量等级
- MALS verified
- 免疫原
- Anti-Rituximab Antibody (ABIN7482277) are expressed from human 293 cells (HEK293).
-
anti-Rituximab antibody
适用: 小鼠 FACS, EIA 宿主: 大鼠 Monoclonal MB2 A4 unconjugated
-
- 应用备注
- This antibody can be paired with other CD20 antibodies to detect CD20 in sandwich ELISA or LFA assay.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 储存条件
- -20 °C
-
- 抗原
- Rituximab
- Abstract
- Rituximab 产品
- 物质类
- Antibody
- 背景
- Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids, Anti-Rituximab Antibodies (RIB-Y35c) is the monoclonal antibody of Rituximab expressed with human HEK293 cells.
-
You are here:
